Cargando…
Meta-analysis and trial sequential analysis of ezetimibe for coronary atherosclerotic plaque compositions
Background: Lipid aggregation, inflammatory cell infiltration, fibrous cap formation, and disruption are the major causes of atherosclerotic cardiovascular disease (ASCVD) and the pathologic features of atherosclerotic plaques. Although ezetimibe’s role in decreasing blood lipids is widely known, th...
Autores principales: | Chai, Bofeng, Shen, Youlu, Li, Yuhong, Wang, Xiaoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084938/ https://www.ncbi.nlm.nih.gov/pubmed/37050908 http://dx.doi.org/10.3389/fphar.2023.1166762 |
Ejemplares similares
-
Meta-analysis and trial sequential analysis of shexiang baoxin pill for coronary slow flow
por: Guo, Hongxin, et al.
Publicado: (2022) -
Statin/ezetimibe combination therapy vs statin monotherapy for carotid atherosclerotic plaque inflammation
por: Oh, Minyoung, et al.
Publicado: (2021) -
The simultaneous occurrence of paraganglioma, Takotsubo syndrome, and Markis type I coronary artery ectasia in the same patient is a rare, high-risk clinical syndrome: a case report
por: Chai, Bofeng, et al.
Publicado: (2023) -
Ezetimibe and Cancer: Is There a Connection?
por: Gu, Jia, et al.
Publicado: (2022) -
Chinese Herbal Medicine for Irritable Bowel Syndrome: A Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials
por: Zheng, Hui, et al.
Publicado: (2021)